University Health Network, Toronto
1,625
259
375
810
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
148 terminated/withdrawn out of 1625 trials
84.6%
-2.0% vs industry average
11%
177 trials in Phase 3/4
8%
67 of 810 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1625)
Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma
Role: lead
Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma
Role: lead
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Role: lead
JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year
Role: collaborator
Capecitabine in ER+/HER2-negative Breast Cancer
Role: lead
A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer
Role: lead
Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients
Role: lead
A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer
Role: lead
Shoulder RA Survey Study
Role: lead
Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study
Role: lead
Transcutaneous Electrical Stimulation for Apnea Detected by Capnography
Role: collaborator
A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer
Role: lead
MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
Role: lead
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
Role: lead
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
Role: lead
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Role: lead
FAZA PET/MRI in CLI Patients Pre and Post Revascularization
Role: lead
Immune Resistance Interrogation Study
Role: lead
Thromboelastography (TEG®) and Platelet Function in Patients on Anti-platelet Agents
Role: collaborator
MCID and PASS for Acute Pain and Quality of Recovery After Orthopedic Surgery
Role: lead